Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2022	$ 2,695	$ 6	$ 216,195	$ (228,169)	$ (408)	$ 20,615	$ 10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Dividends declared - Series B Convertible Preferred Stock	$ 72			(72)
Dividends declared - Series B Convertible Preferred Stock, shares	24,128
Issue common stock - PAVM ATM Facility			557				557
Issue common stock - PAVM ATM Facility, shares		72,134
Conversions - Senior Secured Convertible Note		$ 1	2,026				2,027
Conversions - Senior Secured Convertible Note, shares		288,709
Purchase - Employee Stock Purchase Plan			122		60		182
Purchase - Employee Stock Purchase Plan, shares		25,626
Impact of subsidiary equity transactions			1,189			(1,189)
Stock-based compensation - PAVmed Inc.			1,199				1,199
Stock-based compensation - majority-owned subsidiaries			401			2,820	3,221
Net Loss				(17,931)		(4,283)	(22,214)
Vest - restricted stock awards
Vest - restricted stock awards, shares		6,666
Purchase - majority-owned subsidiary common stock - Employee Stock Purchase Plan						276	276
Issuance - majority-owned subsidiary common stock - Committed Equity Facility, net of financing charges						284	284
Issuance - majority-owned subsidiary common stock - Settlement APA-RDx - Installment Payment						713	713
Issuance - majority-owned subsidiary preferred stock (Series A)						13,625	13,625
Treasury stock			(348)		348
Treasury stock, shares		12,589
Balance at Mar. 31, 2023	$ 2,767	$ 7	221,341	(246,172)		32,861	10,804
Balance, shares at Mar. 31, 2023	1,229,887	6,706,427
Balance at Dec. 31, 2022	$ 2,695	$ 6	216,195	(228,169)	(408)	20,615	10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Dividends declared - Series B Convertible Preferred Stock	$ 78			(78)
Dividends declared - Series B Convertible Preferred Stock, shares	26,123
Issue common stock - PAVM ATM Facility			495				495
Issue common stock - PAVM ATM Facility, shares		133,299
Conversions - Senior Secured Convertible Note			307				307
Conversions - Senior Secured Convertible Note, shares		112,461
Conversions - majority-owned subsidiary common stock - Senior Secured Convertible Note						687	687
Exercise - stock options of majority-owned subsidiary						4	4
Purchase - Employee Stock Purchase Plan			62				62
Purchase - Employee Stock Purchase Plan, shares		34,332
Purchase - majority-owned subsidiary common stock - Employee Stock Purchase Plan						353	353
Impact of subsidiary equity transactions			(1,734)			1,734
Issuance - majority-owned subsidiary preferred stock (Series A-1)						5,670	5,670
Exchange - majority-owned subsidiary preferred stock (Series A and Series A-1)						(24,295)	(24,295)
Issuance - majority-owned subsidiary preferred stock (Series B)						44,285	44,285
Majority-owned subsidiary deemed dividends on preferred stock attributable to noncontrolling interests						(7,495)	(7,495)
Stock-based compensation - PAVmed Inc.			934				934
Stock-based compensation - majority-owned subsidiaries			199			749	948
Net Loss				(15,212)		(3,300)	(18,512)
Balance at Mar. 31, 2024	$ 3,071	$ 9	$ 237,863	$ (309,723)		$ 48,205	$ (20,575)
Balance, shares at Mar. 31, 2024	1,331,336	8,858,597